发明名称 |
THE USE OF CROSS-LINKED HEMOGLOBIN IN TREATING SUBARACHNOID HEMORRHAGE |
摘要 |
Cross-linked hemoglobin infusion following subarachnoid hemorrhage dramatically reduces the tissue area of hypoperfusion and reduces the extent of neuronal damage in the area of hypoperfusion. A therapeutically effective dose ranges from about 1000-5500 mg of body weight and may be administered up to 72 hours after the onset of hemorrhage.
|
申请公布号 |
CA2191952(A1) |
申请公布日期 |
1996.10.17 |
申请号 |
CA19962191952 |
申请日期 |
1996.04.08 |
申请人 |
BAXTER INTERNATIONAL INC. |
发明人 |
BURHOP, KENNETH E.;COLE, DANIEL J. |
分类号 |
A61K38/42;(IPC1-7):A61K38/42 |
主分类号 |
A61K38/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|